Lv41
508 积分 2025-12-26 加入
Conversion surgery after atezolizumab plus bevacizumab therapy for postoperative pulmonary metastasis of hepatocellular carcinoma complicated by polymyalgia rheumatica as an immune-related adverse event
8小时前
已完结
Durable complete response following sequential atezolizumab–bevacizumab and delayed transcatheter arterial embolization in advanced hepatocellular carcinoma
1个月前
已完结
HER2-positive salivary duct carcinoma: durable response to targeted therapy and chemotherapy
2个月前
已关闭
Reproductive and developmental toxicity assessment of palbociclib, a CDK4/6 inhibitor, in Sprague-Dawley rats and New Zealand White rabbits
2个月前
已完结
穿透疗法在复发性高级别脑胶质瘤治疗中的初步应用
2个月前
已完结
Pleural Fluid Cytology Detects Small Cell Carcinoma Transformation in EGFR-Mutant Lung Adenocarcinoma: A Case Report
3个月前
已完结
FRI-232 Imaging-detected immune-related adverse events and clinical outcomes during Atezolizumab–Bevacizumab therapy in unresectable hepatocellular carcinoma: a dual-center study
5个月前
已关闭
Ultra-Sensitive Detection of Bone Metastasis From Accessory Breast Cancer Using HER2 PET/CT: A Case Report
5个月前
已完结
A CASE OF CHILDHOOD ADRENOCORTICAL TUMOR
6个月前
已关闭
CDK4/6 inhibition provides additional efficacy in HER2+, HR+ breast cancer
6个月前
已完结
皖公网安备34019202002308
